Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Remel neisseria meningitidis poly a-d (r30166601) lot 2177820 may fail to agglutinate within the specified minimum reaction time when tested with group d neisseria meningitidis bacteria. however the product continues to correctly identify neisseria meningitidis groups a b and c.